Top Insurance Stocks For 2019

Russell Investments Group Ltd. boosted its holdings in Biogen (NASDAQ:BIIB) by 40.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 183,809 shares of the biotechnology company’s stock after buying an additional 52,654 shares during the period. Russell Investments Group Ltd.’s holdings in Biogen were worth $50,222,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of BIIB. Certified Advisory Corp increased its stake in Biogen by 445.2% in the 1st quarter. Certified Advisory Corp now owns 398 shares of the biotechnology company’s stock worth $108,000 after buying an additional 325 shares in the last quarter. Captrust Financial Advisors purchased a new stake in Biogen in the 4th quarter worth $113,000. Prentiss Smith & Co. Inc. purchased a new stake in Biogen in the 4th quarter worth $123,000. Harel Insurance Investments & Financial Services Ltd. grew its position in shares of Biogen by 77.0% during the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 400 shares of the biotechnology company’s stock valued at $127,000 after purchasing an additional 174 shares in the last quarter. Finally, Bedel Financial Consulting Inc. purchased a new position in shares of Biogen during the first quarter valued at about $131,000. Institutional investors and hedge funds own 87.31% of the company’s stock.

Top Insurance Stocks For 2019: The Blackstone Group L.P.(BX)

Advisors’ Opinion:

  • [By Paul Ausick]

    A week after the killing of 17 students and faculty at Marjory Stoneman Douglas High School in Parkland, Florida, the world’s largest asset management firm, BlackRock Inc. (NYSE: BX) announced that it would begin a series of meetings with gun makers and distributors “to understand their response” to the shooting.

  • [By ]

    The market hasn’t had its needed purge yet says Byron Wien, who is Vice Chairman in the Private Wealth Solutions of Blackstone Group (BX) . “We will retest the February lows [in the markets],” Wien, 86, said on a recent call with media. Wien continues to believe the S&P 500 will rally back after testing the lows, charting a path to 3,000 by year end.

  • [By Lisa Levin] Gainers
    athenahealth, Inc. (NASDAQ: ATHN) shares climbed 23.2 percent to $155.19 after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Evolus, Inc. (NASDAQ: EOLS) gained 21.3 percent to $8.83. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) climbed 18.2 percent to $3.12 after falling 39.86 percent on Friday.
    Gramercy Property Trust (NYSE: GPT) rose 15.6 percent to $27.53 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    EP Energy Corporation (NYSE: EPE) rose 13 percent to $2.26.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) gained 11.9 percent to $7.35.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 11.8 percent to $6.24 after the company posted upbeat quarterly profit.
    Sanchez Energy Corporation (NYSE: SN) shares gained 11.3 percent to $3.56.
    CVR Refining, LP (NYSE: CVRR) shares rose 8.8 percent to $18.875.
    Monaker Group, Inc. (NASDAQ: MKGI) rose 8.7 percent to $2.9683.
    Kosmos Energy Ltd. (NYSE: KOS) shares rose 7.4 percent to $7.40.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 7 percent to $2.88 after climbing 1.89 percent on Friday.
    Cloudera, Inc. (NYSE: CLDR) surged 6 percent to $15.93. Craig-Hallum initiated coverage on Cloudera with a Buy rating.
    Illumina, Inc. (NASDAQ: ILMN) rose 5.1 percent to $257.35. Barclays upgraded Illumina from Equal-Weight to Overweight.

    Check out these big penny stock gainers and losers

Top Insurance Stocks For 2019: Xylem Inc.(XYL)

Advisors’ Opinion:

  • [By Max Byerly]

    Hsbc Holdings PLC cut its holdings in Xylem Inc. (NYSE:XYL) by 7.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 309,799 shares of the industrial products company’s stock after selling 26,335 shares during the quarter. Hsbc Holdings PLC’s holdings in Xylem were worth $23,830,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Xylem Inc (NYSE:XYL) has been assigned an average recommendation of “Buy” from the twelve brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $79.78.

  • [By Lee Samaha]

    Given the need for food and energy in order to support booming population growth in emerging markets, there’ll be a need for significant investment in sustainable water solutions. It’s a compelling long-term investment case, and I think Danaher Corporation (NYSE:DHR), Xylem Inc. (NYSE:XYL) and Pentair plc (NYSE:PNR) are stocks well-placed to play the investment theme. One of the interesting things about water is that there’s no lack of it or difficulty in finding it; the problem is ensuring its quality (for both potable water and wastewater) and transporting it to the right places. This means there’s likely to be good long-term demand for companies serving the market.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Xylem (XYL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Xylem (XYL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Insurance Stocks For 2019: Platform Specialty Products Corporation(PAH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Platform Specialty Products (PAH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Platform Specialty Products Co. (NYSE:PAH) have earned a consensus rating of “Hold” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $14.40.

Leave a Reply

Your email address will not be published. Required fields are marked *